• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏脂贮积症II型:沙特阿拉伯的首例报告。

Mucolipidosis II: first report from Saudi Arabia.

作者信息

Alfadhel Majid, AlShehhi Wafaa, Alshaalan Hesham, Al Balwi Mohammed, Eyaid Wafaa

机构信息

Dr. Majid Alfadhel . Pediatrics, King Abdulaziz Medical City, Sheikh Jabir Al Ahmed al Sabah Street, Al Rimayah, PO Box 22490, 1510 Riyadh 11426, Saudi Arabia .

出版信息

Ann Saudi Med. 2013 Jul-Aug;33(4):382-6. doi: 10.5144/0256-4947.2013.382.

DOI:10.5144/0256-4947.2013.382
PMID:24060719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6078501/
Abstract

BACKGROUND AND OBJECTIVES

Mucolipidosis II (MLII) is characterized by severe global developmental delay, coarse facial features, skeletal deformities, and other systemic involvement. It is caused by a deficiency in N-acetylglucosamine-1 phosphotransferase.

DESIGN AND SETTINGS

This is a case series study conducted at King Abdulaziz Medical City in Riyadh, Saudi Arabia, between 2008-2012.

PATIENTS AND METHODS

We described three unrelated Saudi children who presented with neonatal hyperparathyroidism, microcephaly, craniosynostosis, coarse facial features, cardiac involvement, and skeletal deformities.

RESULTS

The MLII diagnosis was confirmed by assaying enzyme activities in fibroblasts, which showed a severe reduction in hydrolyzed substrates compared to controls, and by identifying a pathogenic homozygous GNPTAB gene mutation. One of the children died at 2 months of age due to severe pulmonary hypertension, and the other two children were still alive at 12 months and 18 months of age, respectively. Both surviving children had severe global developmental delay at 2 months of age.

CONCLUSION

Clinicians should investigate any child presenting with neonatal hyperparathyroidism, craniosynostosis, skeletal deformities, and coarse facial features for MLII.

摘要

背景与目的

II型粘脂贮积症(MLII)的特征为严重的全面发育迟缓、面部特征粗糙、骨骼畸形及其他全身受累情况。它由N-乙酰葡糖胺-1-磷酸转移酶缺乏所致。

设计与地点

这是一项于2008年至2012年在沙特阿拉伯利雅得的阿卜杜勒阿齐兹国王医疗城开展的病例系列研究。

患者与方法

我们描述了三名无血缘关系的沙特儿童,他们表现为新生儿甲状旁腺功能亢进、小头畸形、颅缝早闭、面部特征粗糙、心脏受累及骨骼畸形。

结果

通过检测成纤维细胞中的酶活性(与对照组相比,水解底物严重减少)以及鉴定致病性纯合GNPTAB基因突变,确诊为MLII。其中一名儿童在2个月大时因严重肺动脉高压死亡,另外两名儿童分别在12个月和18个月大时仍存活。两名存活儿童在2个月大时均有严重的全面发育迟缓。

结论

临床医生应对任何出现新生儿甲状旁腺功能亢进、颅缝早闭、骨骼畸形及面部特征粗糙的儿童进行MLII调查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7048/6078501/7e8cd64d6146/asm-4-382f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7048/6078501/6926b405d056/asm-4-382f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7048/6078501/7e8cd64d6146/asm-4-382f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7048/6078501/6926b405d056/asm-4-382f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7048/6078501/7e8cd64d6146/asm-4-382f2.jpg

相似文献

1
Mucolipidosis II: first report from Saudi Arabia.黏脂贮积症II型:沙特阿拉伯的首例报告。
Ann Saudi Med. 2013 Jul-Aug;33(4):382-6. doi: 10.5144/0256-4947.2013.382.
2
Dilated cardiomyopathy in mucolipidosis type 2.2 型黏脂贮积症中的扩张型心肌病。
J Biol Regul Homeost Agents. 2020 Jul-Aug;34(4 Suppl. 2):71-77. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY.
3
Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene.黏脂贮积症II型(I型细胞病)和黏脂贮积症IIIA型(典型的假胡尔勒多营养不良症)是由N-乙酰葡糖胺磷酸转移酶α/β亚基前体基因突变引起的。
Am J Hum Genet. 2006 Mar;78(3):451-63. doi: 10.1086/500849. Epub 2006 Jan 24.
4
GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report.黏脂贮积症 III α/β 型患者中 GNPTAB 基因 c.2404C>T 无义突变:病例报告
BMC Med Genet. 2018 Sep 12;19(1):162. doi: 10.1186/s12881-018-0679-5.
5
Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.鉴定中国东部地区 II/III 型黏脂贮积症患者中 GNPTAB 基因的主要突变及 II 型黏脂贮积症的产前诊断。
Acta Pharmacol Sin. 2019 Feb;40(2):279-287. doi: 10.1038/s41401-018-0023-9. Epub 2018 Jun 5.
6
Prenatal skeletal dysplasia phenotype in severe MLII alpha/beta with novel GNPTAB mutation.伴有新型GNPTAB突变的严重粘脂贮积症II型α/β型的产前骨骼发育异常表型
Gene. 2014 Jun 1;542(2):266-8. doi: 10.1016/j.gene.2014.03.053. Epub 2014 Mar 28.
7
The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: Update on GNPTAB and GNPTG mutations.溶酶体贮积症 II 型、III 型α/β和 III 型γ:GNPTAB 和 GNPTG 突变的最新进展。
Hum Mutat. 2019 Jul;40(7):842-864. doi: 10.1002/humu.23748. Epub 2019 Apr 13.
8
A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.一种新型的患者黏脂贮积症II型突变小鼠模型概括了疾病病理学特征。
J Biol Chem. 2014 Sep 26;289(39):26709-26721. doi: 10.1074/jbc.M114.586156. Epub 2014 Aug 8.
9
Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma.三种新型 GNPTG 基因突变导致 III 型黏脂贮积症γ。
Gene. 2014 Feb 10;535(2):294-8. doi: 10.1016/j.gene.2013.11.010. Epub 2013 Dec 6.
10
Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene.黏脂贮积症 II 型和 III 型 α/β 在巴西:GNPTAB 基因分析。
Gene. 2013 Jul 15;524(1):59-64. doi: 10.1016/j.gene.2013.03.105. Epub 2013 Apr 6.

引用本文的文献

1
Establishment of a Human iPSC Line from Mucolipidosis Type II That Expresses the Key Markers of the Disease.从表达该疾病关键标志物的II型粘脂贮积症中建立人诱导多能干细胞系。
Int J Mol Sci. 2025 Apr 19;26(8):3871. doi: 10.3390/ijms26083871.
2
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension.肺动脉高压中的溶酶体功能障碍与炎症性固醇代谢
Science. 2025 Jan 24;387(6732):eadn7277. doi: 10.1126/science.adn7277.
3
Secondary Hyperparathyroidism in Children with Mucolipidosis Type II (I-Cell Disease): Irish Experience.

本文引用的文献

1
Mucolipidosis type II α/β with a homozygous missense mutation in the GNPTAB gene.II型α/β型粘脂贮积症,GNPTAB基因存在纯合错义突变。
Am J Med Genet A. 2012 May;158A(5):1225-8. doi: 10.1002/ajmg.a.35295. Epub 2012 Apr 11.
2
Mucolipidosis II complicated by severe pulmonary hypertension.II型粘脂贮积症合并严重肺动脉高压。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):192-3. doi: 10.1016/j.ymgme.2011.06.026. Epub 2011 Jul 6.
3
A compound heterozygous GNPTAB mutation causes mucolipidosis II with marked hair color change in a Han Chinese baby.
II型黏脂贮积症(I-细胞病)患儿的继发性甲状旁腺功能亢进:爱尔兰的经验
J Clin Med. 2022 Mar 2;11(5):1366. doi: 10.3390/jcm11051366.
4
GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report.黏脂贮积症 III α/β 型患者中 GNPTAB 基因 c.2404C>T 无义突变:病例报告
BMC Med Genet. 2018 Sep 12;19(1):162. doi: 10.1186/s12881-018-0679-5.
复合杂合性GNPTAB突变导致一名汉族婴儿患II型粘脂贮积症并伴有明显的发色改变。
Am J Med Genet A. 2011 Apr;155A(4):931-4. doi: 10.1002/ajmg.a.33834. Epub 2011 Mar 17.
4
The natural history and osteodystrophy of mucolipidosis types II and III.II型和III型粘脂贮积症的自然病史和骨营养不良
J Paediatr Child Health. 2010 Jun;46(6):316-22. doi: 10.1111/j.1440-1754.2010.01715.x. Epub 2010 Mar 29.
5
Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands.黏脂贮积症 II 型和 III 型 alpha/beta 的表型和基因型:61 例先证者的研究。
J Med Genet. 2010 Jan;47(1):38-48. doi: 10.1136/jmg.2009.067736. Epub 2009 Jul 16.
6
Molecular order in mucolipidosis II and III nomenclature.黏脂贮积症II型和III型命名中的分子秩序
Am J Med Genet A. 2008 Feb 15;146A(4):512-3. doi: 10.1002/ajmg.a.32193.
7
Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene.黏脂贮积症II型(I型细胞病)和黏脂贮积症IIIA型(典型的假胡尔勒多营养不良症)是由N-乙酰葡糖胺磷酸转移酶α/β亚基前体基因突变引起的。
Am J Hum Genet. 2006 Mar;78(3):451-63. doi: 10.1086/500849. Epub 2006 Jan 24.
8
Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA.在患有II型或IIIA型粘脂贮积症的韩国患者中鉴定编码N-乙酰葡糖胺磷酸转移酶α/β亚基的GNPTA(MGC4170)基因突变。
Hum Mutat. 2005 Oct;26(4):308-14. doi: 10.1002/humu.20205.
9
Mucolipidosis II presenting as severe neonatal hyperparathyroidism.表现为严重新生儿甲状旁腺功能亢进的II型粘脂贮积症。
Eur J Pediatr. 2005 Apr;164(4):236-43. doi: 10.1007/s00431-004-1591-x. Epub 2004 Dec 3.
10
Prevalence of lysosomal storage diseases in Portugal.葡萄牙溶酶体贮积症的患病率。
Eur J Hum Genet. 2004 Feb;12(2):87-92. doi: 10.1038/sj.ejhg.5201044.